Clinical Trials Directory

Trials / Unknown

UnknownNCT04365088

Evaluation of the Effects of Pre-operative Deflazacort on Post-operative Pain, Edema and Trismus

Evaluation of the Effects of Pre-operative Deflazacort on Post-operative Pain, Edema and Trismus in Impacted Lower Third Molar Surgery

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Yuzuncu Yil University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Removal of impacted lower third molar teeth is one of the most common oral surgical procedures, and these operations often lead to various complications in patients. Antibiotics, analgesics and/or anti-inflammatory drugs are prescribed for the treatment of complications encountered. Anti-inflammatory is the property of a substance or treatment that reduces inflammation or swelling. Anti-inflammatory drugs make up about half of analgesics, remedying pain by reducing inflammation as opposed to opioids, which affect the central nervous system to block pain signaling to the brain. Based on this information, in this study, it is aimed to evaluate the effects of deflazacort preoperatively on the postoperative pain, swelling and trismus.

Conditions

Interventions

TypeNameDescription
DRUGDeflazacort 30 MG Oral TabletAfter the taken a deflazacort pill once preoperatively (one hour ago), local anesthesia was obtained using 2 ml articaine hydrochloride 40 mg/ml with epinephrine 0.01 mg/ml . The horizontal incision was made with no. 15 scalpel blade and a full thickness mucoperiosteal flap was raised. In all surgical procedures, bone removal and/or tooth sectioning were performed under sterile saline irrigation. Following the extraction, granulation tissues were removed, and bleeding was controlled. Finally, the mucoperiosteal flap was repositioned by 3.0 silk sutures.
DRUGSugar pillSugar pill

Timeline

Start date
2018-12-15
Primary completion
2023-11-15
Completion
2023-12-15
First posted
2020-04-28
Last updated
2023-08-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04365088. Inclusion in this directory is not an endorsement.